Clinical Trials Browser

Recruiting × Hemangiosarcoma × 30 days × Clear all

NCT06898970 2026-03-17

Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma

Phase 2 Recruiting

Hemangiosarcoma

NCT01042379 2026-03-13

I-SPY

Phase 2 Recruiting

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

NCT07432932 2026-02-25

PANTHR-S

Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma

NCT06715579 2026-02-18

CAIR

Hemangiosarcoma

NCT04055220 2026-02-17

REGOSTA

Phase NA Recruiting

Pathologic Complete Response, Bone Neoplasms, Chondrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Patient Compliance, Sarcoma, Ewing, Osteosarcoma, Histiocytoma, Malignant Fibrous